Dicerna Pharmaceuticals Overview

Cambridge, MA
Founded In
Organization Type
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. The company is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others.
Dicerna Pharmaceuticals is a medium pharmaceutical company with 302 employees and an annual revenue of $164.3M that is headquartered in Cambridge, MA.

The Organization’s Mission

We use RNA interference, or RNAi, to create medicines that silence the genes that cause or contribute to disease. Our goal is to provide life-changing therapies to people living with rare and common diseases.

Employee Reviews

Be the first to review!

Do you work at Dicerna Pharmaceuticals?

Help us make this company more transparent

Average Salary
$84,090 yearly

The Culture At Dicerna Pharmaceuticals

Information provided by the company

The Team At Dicerna Pharmaceuticals

Key People

Douglas M. Fambrough III

James Jenson

Dicerna Pharmaceuticals Rankings

Dicerna Pharmaceuticals is ranked #18 on the Best Pharmaceutical Companies to Work For in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Dicerna Pharmaceuticals Salaries

Salary Score
The national average salary for a Dicerna Pharmaceuticals employee in the United States is $84,090 per year. Employees in the top 10 percent can make over $136,000 per year, while employees at the bottom 10 percent earn less than $51,000 per year.
Average Dicerna Pharmaceuticals Salary
$40.43 hourly
Updated March 16, 2023

Highest Paying Jobs At Dicerna Pharmaceuticals

Do you Work At Dicerna Pharmaceuticals?

Help us make this company more transparent.

Dicerna Pharmaceuticals Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

How Would You Rate The Company Culture Of Dicerna Pharmaceuticals?

Have you worked at Dicerna Pharmaceuticals? Help other job seekers by rating Dicerna Pharmaceuticals.

Highest Paying Dicerna Pharmaceuticals Competitors

Competitors of Dicerna Pharmaceuticals include Rigel Pharmaceuticals, Alnylam Pharmaceuticals, and Jounce Therapeutics. The average salaries at Rigel Pharmaceuticals rank the highest, with their employees earning an average salary of $83,403 per year. Employees at Alnylam Pharmaceuticals earn an average of $81,014 per year, and the employees at Jounce Therapeutics earn an average salary of $79,158 per year.
RankCompanyAverage SalaryJobs
1Rigel Pharmaceuticals$83,40310
2Alnylam Pharmaceuticals$81,01449
3Jounce Therapeutics$79,1580
4Bellicum Pharmaceuticals$65,1060
5GenMark Diagnostics$64,5620
6Aprecia Pharmaceuticals$45,6590

Frequently Asked Questions about Dicerna Pharmaceuticals

When was Dicerna Pharmaceuticals founded?

Dicerna Pharmaceuticals was founded in 2007.

How many Employees does Dicerna Pharmaceuticals have?

Dicerna Pharmaceuticals has 302 employees.

How much money does Dicerna Pharmaceuticals make?

Dicerna Pharmaceuticals generates $164.3M in revenue.

What industry is Dicerna Pharmaceuticals in?

Dicerna Pharmaceuticals is in the pharmaceutical industry.

What is Dicerna Pharmaceuticals's mission?

Dicerna Pharmaceuticals's mission statement is "We use RNA interference, or RNAi, to create medicines that silence the genes that cause or contribute to disease. Our goal is to provide life-changing therapies to people living with rare and common diseases."

What type of company is Dicerna Pharmaceuticals?

Dicerna Pharmaceuticals is a public company.

Who are Dicerna Pharmaceuticals's competitors?

Dicerna Pharmaceuticals competitors include Bellicum Pharmaceuticals, Alnylam Pharmaceuticals, Jounce Therapeutics, Aprecia Pharmaceuticals, Rigel Pharmaceuticals, GenMark Diagnostics.

Who works at Dicerna Pharmaceuticals?

Douglas M. Fambrough III (Board Member)

James Jenson (Founder)

Are You An Executive, HR Leader, Or Brand Manager At Dicerna Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

Zippia gives an in-depth look into the details of Dicerna Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dicerna Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Dicerna Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dicerna Pharmaceuticals. The data presented on this page does not represent the view of Dicerna Pharmaceuticals and its employees or that of Zippia.

Dicerna Pharmaceuticals may also be known as or be related to DICERNA PHARMACEUTICALS INC, Dicerna Pharmaceuticals, Dicerna Pharmaceuticals Inc and Dicerna Pharmaceuticals, Inc.